|
 |
 |
|
At
Tidal, we are engaged in offering innovative formulations
that offer sustained value to all our customers.
This entails continuous scaling up in the areas
of technology, products and commercial operations.
We believe that alliancing and partnering can help
in optimizing organization synergies and build inorganic
growth opportunities.
Increased acceptance of generics and favorable legislation,
together with the large volume of branded products
losing patent protection over the coming years,
have led to continued expansion of the global generic
pharmaceuticals market. |
|
|
Tidal is uniquely placed to capitalize on this opportunity by
leveraging its product development capabilities, state of the
art manufacturing capacities and access to its low cost skilled
manpower, which offers potential partners significant supply
chain efficiencies. |
|
 |
|
 |
Integrated
pharmaceutical company |
|
 |
Best
in class GMP Compliant Manufacturing Facilities |
|
 |
Pan
India Sales Force |
|
 |
Robust
Distribution Network |
|
|
 |
|
 |
In-licensing
innovative products |
|
 |
Global
Alliances for Formulations |
|
 |
Alliances
for CRAMS |
|
|
|